BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16876904)

  • 1. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer.
    Huang LJ; Chen SX; Huang Y; Luo WJ; Jiang HH; Hu QH; Zhang PF; Yi H
    Lung Cancer; 2006 Oct; 54(1):87-94. PubMed ID: 16876904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of secreted proteins of non-small cell lung cancer.
    Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H
    Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
    Hsu NY; Ho HC; Chow KC; Lin TY; Shih CS; Wang LS; Tsai CM
    Cancer Res; 2001 Mar; 61(6):2727-31. PubMed ID: 11289154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of dihydrodiol dehydrogenase in the resected stage I non-small cell lung cancer.
    Chen CY; Hsu CP; Hsu NY; Shih CS; Lin TY; Chow KC
    Oncol Rep; 2002; 9(3):515-9. PubMed ID: 11956619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
    He P; Naka T; Serada S; Fujimoto M; Tanaka T; Hashimoto S; Shima Y; Yamadori T; Suzuki H; Hirashima T; Matsui K; Shiono H; Okumura M; Nishida T; Tachibana I; Norioka N; Norioka S; Kawase I
    Cancer Sci; 2007 Aug; 98(8):1234-40. PubMed ID: 17506794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome.
    Wang CL; Wang CI; Liao PC; Chen CD; Liang Y; Chuang WY; Tsai YH; Chen HC; Chang YS; Yu JS; Wu CC; Yu CJ
    J Proteome Res; 2009 Oct; 8(10):4428-40. PubMed ID: 19655816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.
    Chen Y; Zhang H; Xu A; Li N; Liu J; Liu C; Lv D; Wu S; Huang L; Yang S; He D; Xiao X
    Lung Cancer; 2006 Oct; 54(1):95-102. PubMed ID: 16890323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients.
    Kuang P; Zhou C; Li X; Ren S; Li B; Wang Y; Li J; Tang L; Zhang J; Zhao Y
    Lung Cancer; 2012 Aug; 77(2):427-32. PubMed ID: 22534668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modified serum-guided immunoblotting for differential proteomic study of prostate cancer].
    Zhang XB; Tang ZY; Zu XB; Qi L; Ruan JD
    Zhonghua Nan Ke Xue; 2010 May; 16(5):438-44. PubMed ID: 20684326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer.
    Lin TS; Huang HH; Fan YH; Chiou SH; Chow KC
    Oncol Rep; 2007 Mar; 17(3):565-72. PubMed ID: 17273734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Timotheadou E; Skarlos DV; Samantas E; Papadopoulos S; Murray S; Skrickova J; Christodoulou C; Papakostantinou C; Pectasides D; Papakostas P; Kaplanova J; Vrettou E; Karina M; Kosmidis P; Fountzilas G
    Anticancer Res; 2007; 27(6C):4481-9. PubMed ID: 18214064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors in human lung cancer therapy.
    Weinberg OK; Marquez-Garban DC; Fishbein MC; Goodglick L; Garban HJ; Dubinett SM; Pietras RJ
    Cancer Res; 2005 Dec; 65(24):11287-91. PubMed ID: 16357134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer].
    Wei T; Luo RC; Zuo Q; Zhang JY; Miao JX; Lu HF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
    Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.
    Chang GC; Liu KJ; Hsieh CL; Hu TS; Charoenfuprasert S; Liu HK; Luh KT; Hsu LH; Wu CW; Ting CC; Chen CY; Chen KC; Yang TY; Chou TY; Wang WH; Whang-Peng J; Shih NY
    Clin Cancer Res; 2006 Oct; 12(19):5746-54. PubMed ID: 17020980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification and clinical evaluation of lung cancer serum biomarker L-lactate dehydrogenase B].
    Chen Y; Zhang H; Xu AJ; Liu JF; Li N; Wu SS; Huang LY; He DC; Xiao XY
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):577-81. PubMed ID: 17988549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the decay-accelerating factor CD55 as a peanut agglutinin-binding protein and its alteration in non-small cell lung cancers.
    Higuchi M; Endo Y; Suzuki H; Osuka F; Shio Y; Fujiu K; Kanno R; Oishi A; Fujita T; Gotoh M
    Clin Cancer Res; 2006 Nov; 12(21):6367-72. PubMed ID: 17085647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.